Florio G et al. |
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils. |
2000 |
AIDS |
pmid:10853974
|
Nowak P et al. |
Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. |
2003 |
AIDS Res. Hum. Retroviruses |
pmid:12581512
|
Sklar EM |
Post-transplant neurotoxicity: what role do calcineurin inhibitors actually play? |
2006 |
AJNR Am J Neuroradiol |
pmid:16971594
|
Bargalló N et al. |
Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy. |
2000 |
AJNR Am J Neuroradiol |
pmid:10730638
|
Bartynski WS et al. |
Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. |
2001 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:11733324
|
Bartynski WS et al. |
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. |
2004 |
AJNR Am J Neuroradiol |
pmid:14970028
|
Bartynski WS et al. |
Posterior reversible encephalopathy syndrome after solid organ transplantation. |
2008 |
AJNR Am J Neuroradiol |
pmid:18272559
|
Schuuring J et al. |
Severe tacrolimus leukoencephalopathy after liver transplantation. |
2003 Nov-Dec |
AJNR Am J Neuroradiol |
pmid:14625238
|
Oliverio PJ et al. |
Reversible tacrolimus-induced neurotoxicity isolated to the brain stem. |
2000 |
AJNR Am J Neuroradiol |
pmid:10954277
|
Appignani BA et al. |
Neuroimaging findings in patients on immunosuppressive therapy: experience with tacrolimus toxicity. |
1996 |
AJR Am J Roentgenol |
pmid:8623651
|
Srinivas NR |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589592
|
BenÃtez C et al. |
Letter: sublingual dosing of tacrolimus in transplant patients-interesting concept to overcome first pass effects. Authors' reply. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589580
|
Yamamoto S et al. |
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis. |
2008 |
Aliment. Pharmacol. Ther. |
pmid:18549460
|
O'Leary JG |
Editorial: tacrolimus-how low can you go? |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28589579
|
Firpi RJ et al. |
Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent. |
2004 |
Aliment. Pharmacol. Ther. |
pmid:15113371
|
Herrlinger KR et al. |
Infliximab as rescue medication for patients with severe ulcerative/indeterminate colitis refractory to tacrolimus. |
2010 |
Aliment. Pharmacol. Ther. |
pmid:20175769
|
Solari S et al. |
Sublingual tacrolimus administration provides similar drug exposure to per-oral route employing lower doses in liver transplantation: a pilot study. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28261844
|
Nakase H et al. |
Tacrolimus suppresses IL-12/IL23 p40 in Crohn's disease and heals fistulae refractory to anti-TNF-α therapy. |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21434949
|
Nakase H et al. |
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis? |
2011 |
Aliment. Pharmacol. Ther. |
pmid:21198700
|
Hoshino H et al. |
Effects of FK506 on an experimental model of colitis in rats. |
1995 |
Aliment. Pharmacol. Ther. |
pmid:7544633
|